Cargando…
Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas
To determine whether IDH1 mutations are present in primary and relapsed (local and distal) conventional central chondrosarcomas; and secondly, to assess if loss of p16/CDKN2A is associated with tumour grade progression, 102 tumour samples from 37 patients, including material from presenting and rela...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325180/ https://www.ncbi.nlm.nih.gov/pubmed/25432631 http://dx.doi.org/10.1007/s00428-014-1685-4 |
_version_ | 1782356777427271680 |
---|---|
author | Amary, M. Fernanda Ye, Hongtao Forbes, Georgina Damato, Stephen Maggiani, Francesca Pollock, Robin Tirabosco, Roberto Flanagan, Adrienne M. |
author_facet | Amary, M. Fernanda Ye, Hongtao Forbes, Georgina Damato, Stephen Maggiani, Francesca Pollock, Robin Tirabosco, Roberto Flanagan, Adrienne M. |
author_sort | Amary, M. Fernanda |
collection | PubMed |
description | To determine whether IDH1 mutations are present in primary and relapsed (local and distal) conventional central chondrosarcomas; and secondly, to assess if loss of p16/CDKN2A is associated with tumour grade progression, 102 tumour samples from 37 patients, including material from presenting and relapse events, were assessed. All wild-type cases for IDH1 R132 substitutions were also tested for IDH2 R172 and R140 alterations. The primary tumour and the most recent relapse sample were tested for p16/CDKN2A by interphase fluorescence in situ hybridisation. An additional 120 central cartilaginous tumours from different patients were also tested for p16/CDKN2A copy number. The study shows that if an IDH1 mutation were detected in a primary central chondrosarcoma, it is always detected at the time of presentation, and the same mutation is detected in local recurrences and metastatic events. We show that p16/CDKN2A copy number variation occurs subsequent to the IDH1 mutation, and confirm that p16/CDKN2A copy number variation occurs in 75 % of high grade central chondrosarcomas, and not in low grade cartilaginous tumours. Finally, p16/CDKN2A copy number variation is seen in both the IDH1 wild-type and mutant cartilaginous central tumours. |
format | Online Article Text |
id | pubmed-4325180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-43251802015-02-18 Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas Amary, M. Fernanda Ye, Hongtao Forbes, Georgina Damato, Stephen Maggiani, Francesca Pollock, Robin Tirabosco, Roberto Flanagan, Adrienne M. Virchows Arch Original Article To determine whether IDH1 mutations are present in primary and relapsed (local and distal) conventional central chondrosarcomas; and secondly, to assess if loss of p16/CDKN2A is associated with tumour grade progression, 102 tumour samples from 37 patients, including material from presenting and relapse events, were assessed. All wild-type cases for IDH1 R132 substitutions were also tested for IDH2 R172 and R140 alterations. The primary tumour and the most recent relapse sample were tested for p16/CDKN2A by interphase fluorescence in situ hybridisation. An additional 120 central cartilaginous tumours from different patients were also tested for p16/CDKN2A copy number. The study shows that if an IDH1 mutation were detected in a primary central chondrosarcoma, it is always detected at the time of presentation, and the same mutation is detected in local recurrences and metastatic events. We show that p16/CDKN2A copy number variation occurs subsequent to the IDH1 mutation, and confirm that p16/CDKN2A copy number variation occurs in 75 % of high grade central chondrosarcomas, and not in low grade cartilaginous tumours. Finally, p16/CDKN2A copy number variation is seen in both the IDH1 wild-type and mutant cartilaginous central tumours. Springer Berlin Heidelberg 2014-11-29 2015 /pmc/articles/PMC4325180/ /pubmed/25432631 http://dx.doi.org/10.1007/s00428-014-1685-4 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Article Amary, M. Fernanda Ye, Hongtao Forbes, Georgina Damato, Stephen Maggiani, Francesca Pollock, Robin Tirabosco, Roberto Flanagan, Adrienne M. Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title_full | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title_fullStr | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title_full_unstemmed | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title_short | Isocitrate dehydrogenase 1 mutations (IDH1) and p16/CDKN2A copy number change in conventional chondrosarcomas |
title_sort | isocitrate dehydrogenase 1 mutations (idh1) and p16/cdkn2a copy number change in conventional chondrosarcomas |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325180/ https://www.ncbi.nlm.nih.gov/pubmed/25432631 http://dx.doi.org/10.1007/s00428-014-1685-4 |
work_keys_str_mv | AT amarymfernanda isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT yehongtao isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT forbesgeorgina isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT damatostephen isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT maggianifrancesca isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT pollockrobin isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT tiraboscoroberto isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas AT flanaganadriennem isocitratedehydrogenase1mutationsidh1andp16cdkn2acopynumberchangeinconventionalchondrosarcomas |